Reilly Financial Advisors LLC Acquires 300 Shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Reilly Financial Advisors LLC lifted its holdings in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 138.9% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 516 shares of the financial services provider’s stock after buying an additional 300 shares during the period. Reilly Financial Advisors LLC’s holdings in iShares Nasdaq Biotechnology ETF were worth $56,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of IBB. Ellis Investment Partners LLC boosted its stake in shares of iShares Nasdaq Biotechnology ETF by 10,590.0% during the 1st quarter. Ellis Investment Partners LLC now owns 1,761,815 shares of the financial services provider’s stock worth $1,761,000 after purchasing an additional 1,745,334 shares during the period. Commerce Bank boosted its stake in shares of iShares Nasdaq Biotechnology ETF by 1.5% during the 1st quarter. Commerce Bank now owns 710,753 shares of the financial services provider’s stock worth $79,462,000 after purchasing an additional 10,414 shares during the period. Joseph P. Lucia & Associates LLC purchased a new position in shares of iShares Nasdaq Biotechnology ETF during the 1st quarter worth about $2,049,000. Crestwood Advisors Group LLC boosted its stake in shares of iShares Nasdaq Biotechnology ETF by 5.0% during the 1st quarter. Crestwood Advisors Group LLC now owns 217,133 shares of the financial services provider’s stock worth $24,275,000 after purchasing an additional 10,390 shares during the period. Finally, Commonwealth Equity Services LLC boosted its stake in shares of iShares Nasdaq Biotechnology ETF by 1.0% during the 1st quarter. Commonwealth Equity Services LLC now owns 205,014 shares of the financial services provider’s stock worth $22,920,000 after purchasing an additional 1,936 shares during the period. Hedge funds and other institutional investors own 72.66% of the company’s stock.

Shares of IBB stock traded down $1.31 during trading hours on Friday, reaching $105.07. 2,026,649 shares of the stock were exchanged, compared to its average volume of 2,331,389. iShares Nasdaq Biotechnology ETF has a 12-month low of $89.01 and a 12-month high of $122.97. The stock’s 50-day moving average is $106.83.

About iShares Nasdaq Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Featured Article: What is a Reverse Stock Split?

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.